EDT vs. AKU, GEN, LMD, LXG, SQD, DXD, MBI, BUX, CRL, and KSI
Should you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Akumin (AKU), GeneNews (GEN), LED Medical Diagnostics (LMD), LexaGene (LXG), SQI Diagnostics (SQD), 3D Signatures (DXD), Med Biogene (MBI), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), and kneat.com (KSI). These companies are all part of the "medical" sector.
Spectral Medical vs.
Spectral Medical (TSE:EDT) and Akumin (TSE:AKU) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, community ranking, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.
Spectral Medical has a net margin of 0.00% compared to Akumin's net margin of -34.67%. Akumin's return on equity of -483.86% beat Spectral Medical's return on equity.
13.0% of Spectral Medical shares are owned by institutional investors. Comparatively, 30.3% of Akumin shares are owned by institutional investors. 18.2% of Spectral Medical shares are owned by insiders. Comparatively, 33.0% of Akumin shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Spectral Medical has higher earnings, but lower revenue than Akumin. Spectral Medical is trading at a lower price-to-earnings ratio than Akumin, indicating that it is currently the more affordable of the two stocks.
Spectral Medical received 106 more outperform votes than Akumin when rated by MarketBeat users. Likewise, 65.17% of users gave Spectral Medical an outperform vote while only 64.10% of users gave Akumin an outperform vote.
Spectral Medical has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Comparatively, Akumin has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500.
In the previous week, Spectral Medical's average media sentiment score of 0.67 beat Akumin's score of 0.00 indicating that Spectral Medical is being referred to more favorably in the media.
Summary
Spectral Medical beats Akumin on 7 of the 13 factors compared between the two stocks.
Get Spectral Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Spectral Medical Competitors List
Related Companies and Tools
This page (TSE:EDT) was last updated on 2/22/2025 by MarketBeat.com Staff